Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Expect an announcement re financing in the next two weeks

<< Previous

Bullboard Posts

Next >>

Comment by MMABStraderon Aug 23, 2022 5:01pm

219 Views

Post# 34915418

RE:RE:Expect an announcement re financing in the next two weeks

MM... good reply. I wasn't aware of what all the strike prices are for the outstanding warrants.

I still think there will be an announcement by September 9, regarding where they will get funding for at least two more quarters. I think short term they need at least $6 million, maybe $7 million more to cover through first quarter 2023..

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project